Comparison · NCT00829686-8719fa83
Septra DS vs No Intervention: Clinical Improvement at 7 Days After Incision and Drainage
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Septra DS vs No Intervention: Clinical Improvement at 7 Days After Incision and Drainage. Trial comparisons, record NCT00829686-8719fa83. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00829686-8719fa83
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.778 | 0.548 | 0.91 | wilson | |
| Risk in group 2 | 0.769 | 0.497 | 0.918 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00855 | -0.265 | 0.311 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.01 | 0.687 | 1.49 | log | |
| Odds ratio, group 1 over group 2 | 1.05 | 0.191 | 5.76 | log | |
| Number needed to treat, for one more participant with the outcome on Septra DS than on No Intervention | 117 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: no intervention.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Septra DS | Septra DS (800/160) two pills PO BID x 7 days | 14 | 18 | OG001 |
| Group 2 | No Intervention | No antibiotic | 10 | 13 | OG000 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Clinical Improvement at 7 Days After Incision and Drainage
- Description
- improving wound without evidence of fever, worsening cellulitis or induration
- Time frame
- 7 days
- Population
Source ClinicalTrials.gov
Trial
- Title
- Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
- NCT number
- NCT00829686
- Phases
- NA
- Conditions
- Abscess
- Interventions
- Septra
- Lead sponsor
- 59th Medical Wing
- Results first posted
- 2009-07-28
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00829686?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00829686-8719fa83